** Insurer Lemonade Inc's shares jump as much as 13%, last up 10.6% to $44.44
** Morgan Stanley upgrades company's shares to "equal-weight" from "underweight"; raises PT to $42 from $23
** Company's shares closed up 17% on Tuesday after LMND's investor day
** Company at its investor day unveiled plan to grow its business from $1 bln in premiums to $10 bln over the next few years
** Morgan Stanley says that while LMND's targets are ambitious, management outlined specific strategies on how to achieve the growth targets
** Brokerage adds the most important element of the investor day for it was the goal to achieve net profit exiting 2027, which is significantly better than Wall Street consensus and its expectations
** 1 of 10 brokerages rate the stock "buy", 6 "hold" and 3 "sell" or lower; median PT $21 - LSEG
** As of last close, LMND shares more than doubled YTD
(Reporting by Arasu Kannagi Basil in Bengaluru) ((ArasuKannagi.Basil@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.